Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery

NCT01927302 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-08-11

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of treatment for specific language deficits in people with aphasia. In addition to language and cognitive measures, changes in brain function will also be gathered before and after the treatment is administered in order to track any changes resulting from receiving treatment.

Conditions

  • Aphasia
  • Dysgraphia
  • Anomia
  • Agrammatism
  • Stroke

Interventions

BEHAVIORAL

Treatment Focusing on Naming Objects

Treatment will be administered from week 0 until week 12.

BEHAVIORAL

Treatment Focusing on Improving Spelling Abilities

Treatment will be administered from week 0 until week 12.

BEHAVIORAL

Treatment Focusing on Improving Sentence Processing

Treatment will be administered from week 0 until week 12.

BEHAVIORAL

No Treatment

No treatment will be administered.

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH
  • National Institutes of Health (NIH)

    collaborator NIH
  • Northwestern University

    lead OTHER

Principal Investigators

  • Cynthia K Thompson, PhD · Northwestern University

  • David Caplan, MDCM, PhD · Harvard University Massachusetts General Hospital

  • Brenda Rapp, PhD · Johns Hopkins University

  • Swathi Kiran, PhD, CCC-SLP · Boston University

  • Todd B Parrish, PhD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2019-03-27
Completion
2019-03-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01927302 on ClinicalTrials.gov